Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas B Brunner

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 23, 2019
[Pravastatin is capable to reduce radiation induced fibrosis after head-and-neck treatment]Thomas B Brunner
Current Oncology Reports|January 18, 2013
Neoadjuvant therapy for potentially resectable pancreatic cancer: an emerging paradigm?Thomas B Brunner
Best Practice & Research. Clinical Gastroenterology|September 21, 2016
The rationale of combined radiotherapy and chemotherapy - Joint action of Castor and PolluxThomas B Brunner
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 27, 2014
[Is D2 and D1 lymphadenectomy for patients with gastric cancer beneficial?]Thomas B Brunner
Best Practice & Research. Clinical Gastroenterology|September 21, 2016
Chemoradiotherapy, the backbone of radiotherapy in gastrointestinal oncologyThomas B Brunner, Thomas Seufferlein
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 19, 2008
Radiotherapy in pancreatic cancerGunther Klautke, Thomas B Brunner
Best Practice & Research. Clinical Gastroenterology|September 21, 2016
Radiation therapy in cholangiocellular carcinomasThomas B Brunner, Thomas Seufferlein
Best Practice & Research. Clinical Gastroenterology|September 21, 2016
Pancreatic cancer chemoradiotherapyThomas B Brunner, Thomas Seufferlein
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 10, 2018
[Adjuvant chemotherapy with cisplatin and gemcitabine after radiochemotherapy with curative intent does not improve relapse-free survival in nasopharyngeal cancer patients with persistently detectable EBV DNA]Christoph Willich, Thomas B Brunner
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 8, 2010
Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinomaThomas B Brunner, Cynthia L Eccles
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 23, 2019
[Pravastatin is capable to reduce radiation induced fibrosis after head-and-neck treatment]Thomas B Brunner
Current Oncology Reports|January 18, 2013
Neoadjuvant therapy for potentially resectable pancreatic cancer: an emerging paradigm?Thomas B Brunner
Best Practice & Research. Clinical Gastroenterology|September 21, 2016
The rationale of combined radiotherapy and chemotherapy - Joint action of Castor and PolluxThomas B Brunner
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 27, 2014
[Is D2 and D1 lymphadenectomy for patients with gastric cancer beneficial?]Thomas B Brunner
Best Practice & Research. Clinical Gastroenterology|September 21, 2016
Chemoradiotherapy, the backbone of radiotherapy in gastrointestinal oncologyThomas B Brunner, Thomas Seufferlein
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 19, 2008
Radiotherapy in pancreatic cancerGunther Klautke, Thomas B Brunner
Best Practice & Research. Clinical Gastroenterology|September 21, 2016
Radiation therapy in cholangiocellular carcinomasThomas B Brunner, Thomas Seufferlein
Best Practice & Research. Clinical Gastroenterology|September 21, 2016
Pancreatic cancer chemoradiotherapyThomas B Brunner, Thomas Seufferlein
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 10, 2018
[Adjuvant chemotherapy with cisplatin and gemcitabine after radiochemotherapy with curative intent does not improve relapse-free survival in nasopharyngeal cancer patients with persistently detectable EBV DNA]Christoph Willich, Thomas B Brunner
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 8, 2010
Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinomaThomas B Brunner, Cynthia L Eccles
Pageof 10